.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Moodys
US Army
Cantor Fitzgerald
Harvard Business School
Baxter
Farmers Insurance
Cerilliant
Queensland Health
Mallinckrodt

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,859,038

« Back to Dashboard

Summary for Patent: 5,859,038

Title: Method for treatment of helicobacter pylori infections
Abstract:The present invention relates to a method for treating helicobacter pylori bacteria or for preventing troubles or diseases or infections due to helicobacter pylori bacteria, said method comprising administering to a subject an effective amount of a compound selected in the group consisting of: compound A of formula ##STR1## compound B of formula ##STR2## and mixture of said compounds A and B.
Inventor(s): Rossignol; Jean-Fran.cedilla.ois (Clearwater, FL)
Assignee: Romark Laboratories, L.C. (Tampa, FL)
Application Number:08/644,153
Patent Claim Types:
see list of patent claims
Use; Compound;

No matches for this query

International Patent Family for Patent: 5,859,038

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)9600866► Subscribe
African Regional IP Organization (ARIPO)645► Subscribe
African Regional IP Organization (ARIPO)9901675► Subscribe
African Regional IP Organization (ARIPO)1103► Subscribe
Argentina008355► Subscribe
Argentina057242► Subscribe
Austria218557► Subscribe
Austria228839► Subscribe
Austria267798► Subscribe
Austria281166► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Novartis
Baxter
Julphar
Merck
Healthtrust
US Army
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot